Associate Professor of Molecular and Integrative Physiology
Associate Professor of Internal Medicine
[email protected]
Available to mentor
Lei Yin, MD, PhD
Associate Professor
-
Center MemberCaswell Diabetes Institute
-
Zhang D, Zhao Y, Zhang G, Lank D, Cooke S, Wang S, Nuotio-Antar A, Tong X, Yin L. Mol Metab, 2024 Jul; 85: 101957Journal ArticleSuppression of hepatic ChREBP⍺-CYP2C50 axis-driven fatty acid oxidation sensitizes mice to diet-induced MASLD/MASH.
DOI:10.1016/j.molmet.2024.101957 PMID: 38740087 -
Wang S, Gao J, Yang M, Zhang G, Yin L, Tong X. Adv Sci (Weinh), 2024 Oct 29; e2405678Journal ArticleOPN-Mediated Crosstalk Between Hepatocyte E4BP4 and Hepatic Stellate Cells Promotes MASH-Associated Liver Fibrosis.
DOI:10.1002/advs.202405678 PMID: 39473081 -
Yin L. 2023 Oct 1;PresentationNoncanonical Actions of ChREBP∝ in Diet-Induced Liver Fibrosis.
-
Yin L. 2023 Jun 1;PresentationNoncanonical Actions of ChREBP∝ in Diet-Induced Liver Fibrosis.
-
Wang S, Yang M, Li P, Sit J, Wong A, Rodrigues K, Lank D, Zhang D, Zhang K, Yin L, Tong X. Diabetes, 2023 Mar 1; 72 (3): 348 - 361.Journal ArticleHigh-Fat Diet-Induced DeSUMOylation of E4BP4 Promotes Lipid Droplet Biogenesis and Liver Steatosis in Mice.
DOI:10.2337/db22-0332 PMID: 36508222 -
Rodrigues K, Hussain R, Cooke S, Zhang G, Zhang D, Yin L, Tong X. Metab Target Organ Damage, 2023 3 (4):Journal ArticleFructose as a novel nutraceutical for acetaminophen (APAP)-induced hepatotoxicity.
DOI:10.20517/mtod.2023.28 PMID: 39193224 -
Yin L. 2022 Oct 1;PresentationHepatocyte ChREBPalpha : a friend or foe in the pathogenesis of chronic liver diseases
-
Yin L. 2022 Feb 1;PresentationHepatocyte ChREBPa: unexpected protector against diet-induced NAFLD/NASH